(Q39666587)

13 September 2017

title

Digital fluoroscopy to quantify lung tumor motion: potential for patient-specific planning target volumes (English)

1 reference

13 September 2017

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00713-2

18 March 2024

author name string

Mark Ruschin

2

1 reference

13 September 2017

Romeo Tirona

3

1 reference

13 September 2017

Katharina E. Sixel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529776

18 March 2024

Patrick C. F. Cheung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529776

18 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0360301603007132?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00713-2

https://api.elsevier.com/content/article/PII:S0360301603007132?httpAccept=text/plain

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00713-2

International Journal of Radiation Oncology Biology Physics

18 March 2024

published in

1 reference

13 September 2017

volume

57

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

717-723

1 reference

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Combined modality therapy in NSCLC.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Three-dimensional conformal radiotherapy in bronchogenic carcinoma: considerations for implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Relating radiation-induced regional lung injury to changes in pulmonary function tests

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

3D conformal radiotherapy in the sagittal plane for centrally located thoracic tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Fluoroscopic study of tumor motion due to breathing: facilitating precise radiation therapy for lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Integration of digital fluoroscopy with CT-based radiation therapy planning of lung tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900713-2

7 January 2021

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer

13

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)00713-2

18 March 2024

Identifiers

1 reference

13 September 2017

1 reference